BIOCOM Hot Technology Series: Microbiome Products Beyond FMT - Challenges and Opportunities

Microbiome-based therapies have been a hot area of research for the last decade and promising early-stage therapies are in clinical development. While these are great opportunities in this space to address patients’ unmet medical needs, there are significant challenges associated with delivering microbiome derived therapies to patients.

Bosch: Critial Factors for Connected Medical Devices of the Future

Bosch Conversations: Critical Factors for Connected Medical Devices of the Future, will feature a select group of healthcare executives and innovators who will gather to network and learn firsthand about critical factors needed to ensure success for connected medical devices of the future. This Bosch Conversations Event is brought to you by Bosch and HealthFactors, and co-sponsored by MASSMedic, Halloran Consulting Group, and Health Advances.

Clinical operations breakfast: Science 37 at Sanofi

One of the biggest challenges in clinical research is getting and keeping patients engaged. It is estimated that about 70% of trial delays are caused by slow patient recruitment. Science 37 has changed the paradigm by bringing the trial to the patient.

Clinical operations breakfast: eTMF at Alnylam

Every life science company faces two basic dilemmas as they move through clinical development creating the story of the program for future scrutiny: 1) to eTMF or not to eTMF, and 2) to outsource oversight for the Trial Master File to a CRO or spend internal resources on management?

Halloran Announces Participation in September Industry Events

Halloran is pleased to announce that we will be participating in three industry events in the month of September. Thought leaders from Halloran will be speaking on panels, presenting on key trends and meeting with peers to discuss opportunities and challenges facing pharma, biotech, and life sciences.
Subscribe to Events